Precision Research Institute is one of the top San Diego clinical research facilities with two locations; Central San Diego and Chula Vista. We have a leading team of doctors, medical personnel and research specialists offering phase II to phase IV clinical research studies.

(619) 501-0371
info@prisandiego.com
1292 Euclid Ave Suite 115, Chula Vista, CA 91910

Copyright © 2011 Precision Research Institute. All Rights Reserved.

Image Alt
  /  Our Studies

Our Studies

Our Studies

Medical Research Studies

Precision Research Institute (PRI) offers high-quality clinical research studies. We offer medical research studies in the areas of gastroenterology, internal medicine, women’s health and much more. Click on a study category below to see medical research studies currently looking for participants.

Our Current Studies

PRI Open Protocol Summaries

INDICATION

AGE CRITERIA

DESCRIPTION

Eosinophilic Esophagitis

≥ 18 years

A Randomized, Double-blind, Placebo-Controlled 24-Week Induction Study of APT-1011, followed by a Singlearm Open-label Extension, in Adult Subjects with Eosinophilic Esophagitis.

Ulcerative Colitis

> 18 & up

A Study to Determine the Association Between Genetic Variants and Ex-Vivo Peripheral Blood Mononuclear Cell (PBMC) Activity in Subjects with Diagnosis of Ulcerative Colitis or Crohn’s Disease

Cirrhosis

≥ 18 and ≤70 yrs.

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD) TABLETS FOR THE DELAY OF ENCEPHALOPATHY DECOMPENSATION IN CIRRHOSIS (RED-C)

Observational Study

45 yrs or older

Prospective, multi-center observational study for the clinical validation of the Next Generation test for blood based screening of colorectal cancer.

Cancer Screening Collection Study

≥ 50 and ≤ 80 yrs.

Cancer Screening Collection Study.

UC of the Rectum

≥ 18 yrs.

A Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Safety and Efficacy of Once-Daily and Twice-Daily Dosing of a Novel Hydrocortisone Acetate 90 mg Suppository Formulation Administered with the Sephure® Suppository Applicator in Subjects with Ulcerative Colitis of the Rectum

Diabetic Gastroparesis

18-75 years

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Diabetic Gastroparesis

NASH

> 65 years

Randomize, Double-Blind, Placebo-Controlled, Phase 2 Studies pf siRNA Gene Silencing for the Treatmrnt of Non-Alcoholic Steatohepatitis(NASH) in Participants with Genetic Risk Factors

Chronic Hep B Virus

≥ 18 years

Phase 3 Multi Center, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in HBeAg-negative Nucleos(t)ide Analogue treated Participants with Chronic Hepatitis B Virus (B Well 1)

Cancer Screening Collection Study

45-84

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode (ECLIPSE)

Our Upcoming Studies

PRI Upcoming Protocol Summaries

INDICATION

AGE CRITERIA

DESCRIPTION

Healthy Patient (Implant Procedure)

18-65 yrs.

AN OPEN-LABEL, PHASE 1 STUDY TO EVALUATE THE ENGRAFTMENT OF VC-01TM COMBINATION
PRODUCT IN THE PRE-PERITONEUM AND SUBCUTANEOUS LAYERS OF NORMAL HEALTHY VOLUNTEERS

Observational Study

45 yrs or older

Prospective, multi-center observational study for the clinical validation of the Next Generation test for blood based screening of colorectal cancer.

Anal fissure-Phase: 2b

18-75 yrs.

A study to investigate anal pain reduction with TAVT-119 (amlodipine besylate) gel compared with placebo gel in participants.

Address

292 Euclid Ave
Suite 115
San Diego, CA 92114

Phone

(619) 501-0390

Cell

(619) 861-5314

Fax

(619) 501-0371-4769

Email

info@prisandiego.com